Compression Therapy Following Endothermal Ablation
COMETA
Multicentre Randomised Controlled Trial of Compression Therapy Following Endothermal Ablation (COMETA)
1 other identifier
interventional
204
1 country
1
Brief Summary
This study will be looking at the effect of compression therapy in patients having endovenous treatment for truncal incompetence of their varicose veins using either radiofrequency ablation (RFA) or endovenous laser therapy (EVLT). Patients will be randomised to either the compression group (group A) or the no compression group (group B). The pain scores, compliance, quality of life scores, occlusion rate at 6 months as well as the cost effectiveness of each intervention will be assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2015
CompletedFirst Submitted
Initial submission to the registry
August 4, 2015
CompletedFirst Posted
Study publicly available on registry
August 13, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2019
CompletedResults Posted
Study results publicly available
July 27, 2020
CompletedSeptember 6, 2022
August 1, 2022
4 years
August 4, 2015
June 4, 2020
August 4, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient's Post-procedure Pain Score Using a Visual Analogue Scale (VAS)
Patients indicating level of pain they were having using a VAS scale. The scale is a 100mm line drawn going from 0-100 (0=no pain; 100=worse pain)
Up to 10 days
Secondary Outcomes (9)
The Generic Quality of Life Score Using the EQ-5D Score
Up to 6 months
The Specific Quality of Life Score Using the Aberdeen Varicose Vein Questionnaire (AVVQ) Score
Up to 6 months
The Specific Quality of Life Score Using the CIVIQ Score
Up to 6 months
The Clinical Score Using the Venous Clinical Severity Score
Up to 6 months
The Degree of Bruising and Phlebitis
Up to 6 months
- +4 more secondary outcomes
Study Arms (2)
Compression
ACTIVE COMPARATORPatients randomised to this group will be asked to wear Class II compression stockings for 1 week
No Compression
NO INTERVENTIONPatients randomised to this group will not be provided with any compression
Interventions
This study will be looking at the effect of compression therapy in patients having endothermal treatment for truncal incompetence of their varicose veins
Eligibility Criteria
You may qualify if:
- Adults over 18 years of age
- Symptomatic GSV or SSV vein reflux \> 0.5 seconds on colour Duplex
You may not qualify if:
- Current DVT
- Recurrent varicose veins
- Patients requiring adjuvant treatment of varicose veins
- Arterial disease (ABPI\<0.8)
- Vein diameter \< 3mm
- Patient who are unwilling to participate
- Inability or unwillingness to complete questionnaires
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Charing Cross Hospital, Imperial College London
London, W6 8RF, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
1. Power of the study was decreased from 90% to 80%. 2. The use of analgesia was not recorded so that it is unclear whether the pain score observed was with or without analgesia.
Results Point of Contact
- Title
- Mr Roshan Bootun
- Organization
- Imperial College London
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 4, 2015
First Posted
August 13, 2015
Study Start
May 1, 2015
Primary Completion
May 1, 2019
Study Completion
May 1, 2019
Last Updated
September 6, 2022
Results First Posted
July 27, 2020
Record last verified: 2022-08